These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Bone mineral density in patients on long-term therapy with levothyroxine]. Korsić M, Cvijetić S, Dekanić-Ozegović D, Bolanća S, Kozić B. Lijec Vjesn; 1998 May; 120(5):103-5. PubMed ID: 9748785 [Abstract] [Full Text] [Related]
6. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia. Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M. Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524 [Abstract] [Full Text] [Related]
8. Lovastatin effects on bone mineral density in postmenopausal women with type 2 diabetes mellitus. Safaei H, Janghorbani M, Aminorroaya A, Amini M. Acta Diabetol; 2007 Jun; 44(2):76-82. PubMed ID: 17530471 [Abstract] [Full Text] [Related]
9. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy. Popp AW, Bodmer C, Senn C, Fuchs G, Kraenzlin ME, Wyss H, Birkhaeuser MH, Lippuner K. Maturitas; 2006 Jan 20; 53(2):191-200. PubMed ID: 16368472 [Abstract] [Full Text] [Related]
10. Association between androgen receptor gene polymorphism and bone density in older women using hormone replacement therapy. Retornaz F, Paris F, Lumbroso S, Audran F, Tigoulet F, Michelon C, Jeandel C, Sultan C, Blain H. Maturitas; 2006 Nov 20; 55(4):325-33. PubMed ID: 16759824 [Abstract] [Full Text] [Related]
11. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience. Sethi BK, Chadha M, Modi KD, Kumar KM, Mehrotra R, Sriram U. J Assoc Physicians India; 2008 Jun 20; 56():418-24. PubMed ID: 18822620 [Abstract] [Full Text] [Related]
14. Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L-thyroxine suppressive therapy. Mazokopakis EE, Starakis IK, Papadomanolaki MG, Batistakis AG, Papadakis JA. Curr Med Res Opin; 2006 Jul 20; 22(7):1369-73. PubMed ID: 16834835 [Abstract] [Full Text] [Related]
16. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy. Legroux-Gerot I, Vignau J, Collier F, Cortet B. Calcif Tissue Int; 2008 Nov 20; 83(5):315-23. PubMed ID: 18836675 [Abstract] [Full Text] [Related]
17. Difference in bone acquisition among hormonally treated postmenopausal women with normal and low bone mass. Taechakraichana N, Jaisamrarn U, Panyakhamlerd K, Chaikittisilpa S, Limpaphayom K. J Med Assoc Thai; 2001 Oct 20; 84 Suppl 2():S586-92. PubMed ID: 11853286 [Abstract] [Full Text] [Related]
18. One-year soy isoflavone supplementation prevents early postmenopausal bone loss but without a dose-dependent effect. Huang HY, Yang HP, Yang HT, Yang TC, Shieh MJ, Huang SY. J Nutr Biochem; 2006 Aug 20; 17(8):509-17. PubMed ID: 16563719 [Abstract] [Full Text] [Related]